SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-21-000052
Filing Date
2021-08-05
Accepted
2021-08-05 16:13:27
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20210630.htm   iXBRL 10-Q 1269555
2 EX-31.1 a2021-q210xqex311.htm EX-31.1 10912
3 EX-31.2 a2021-q210xqex312.htm EX-31.2 10930
4 EX-32.1 a2021-q210xqex321.htm EX-32.1 4932
5 EX-32.2 a2021-q210xqex322.htm EX-32.2 4962
11 PIPELINE abus-20210630_g1.jpg GRAPHIC 58228
  Complete submission text file 0001447028-21-000052.txt   5295675

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20210630.xsd EX-101.SCH 37437
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20210630_cal.xml EX-101.CAL 50774
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20210630_def.xml EX-101.DEF 147423
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20210630_lab.xml EX-101.LAB 422124
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20210630_pre.xml EX-101.PRE 260983
12 EXTRACTED XBRL INSTANCE DOCUMENT abus-20210630_htm.xml XML 855717
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 211148337
SIC: 2834 Pharmaceutical Preparations